Skip to content

Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal

Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02748824
Acronym
AMDIncidencePT
Enrollment
5996
Registered
2016-04-22
Start date
2016-07-31
Completion date
2017-10-31
Last updated
2017-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-Related Macular Degeneration

Keywords

Age- Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Cataract

Brief summary

To assess the five-year incidence of AMD in a population from the central region of Portugal, previously phenotypically characterized.

Detailed description

Subjects who participated in the Epidemiologic Coimbra Eye Study (NCT01298674) between 2009 and 2013 will attend a single visit, after giving informed consent.

Interventions

None listed

Sponsors

Association for Innovation and Biomedical Research on Light and Image
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects who participated in the Epidemiologic Coimbra Eye Study (NCT01298674) and that were phenotyped; * Subjects capable of understanding the information about the study and to give their informed consent to enter the study; * Subjects willing and able to comply with the study procedures.

Exclusion criteria

\- Not applicable

Design outcomes

Primary

MeasureTime frame
Phenotypic classification of AMD in the five-year clinical visit. Comparison of this classification with the grading of 5 years ago.5 years

Secondary

MeasureTime frame
Risk factors: Demographic, Medical history, Ophthalmologic history, Family history of AMD, Systemic comorbidities and medication, Nutritional and Lifestyle habits. Signs of AMD on the multimodal evaluation.5 years

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026